244 related articles for article (PubMed ID: 28182669)
1. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
[TBL] [Abstract][Full Text] [Related]
2. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
3. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.
Lesca G; Rudolf G; Bruneau N; Lozovaya N; Labalme A; Boutry-Kryza N; Salmi M; Tsintsadze T; Addis L; Motte J; Wright S; Tsintsadze V; Michel A; Doummar D; Lascelles K; Strug L; Waters P; de Bellescize J; Vrielynck P; de Saint Martin A; Ville D; Ryvlin P; Arzimanoglou A; Hirsch E; Vincent A; Pal D; Burnashev N; Sanlaville D; Szepetowski P
Nat Genet; 2013 Sep; 45(9):1061-6. PubMed ID: 23933820
[TBL] [Abstract][Full Text] [Related]
4. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.
Fernández-Marmiesse A; Kusumoto H; Rekarte S; Roca I; Zhang J; Myers SJ; Traynelis SF; Couce ML; Gutierrez-Solana L; Yuan H
Mov Disord; 2018 Jul; 33(6):992-999. PubMed ID: 29644724
[TBL] [Abstract][Full Text] [Related]
5. De novo GRIN2A variants associated with epilepsy and autism and literature review.
Mangano GD; Riva A; Fontana A; Salpietro V; Mangano GR; Nobile G; Orsini A; Iacomino M; Battini R; Astrea G; Striano P; Nardello R
Epilepsy Behav; 2022 Apr; 129():108604. PubMed ID: 35217385
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.
Yuan H; Hansen KB; Zhang J; Pierson TM; Markello TC; Fajardo KV; Holloman CM; Golas G; Adams DR; Boerkoel CF; Gahl WA; Traynelis SF
Nat Commun; 2014; 5():3251. PubMed ID: 24504326
[TBL] [Abstract][Full Text] [Related]
7. GRIN2A mutations in epilepsy-aphasia spectrum disorders.
Yang X; Qian P; Xu X; Liu X; Wu X; Zhang Y; Yang Z
Brain Dev; 2018 Mar; 40(3):205-210. PubMed ID: 29056244
[TBL] [Abstract][Full Text] [Related]
8. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
[TBL] [Abstract][Full Text] [Related]
9. GRIN2A-related epilepsy and speech disorders: A comprehensive overview with a focus on the role of precision therapeutics.
Samanta D
Epilepsy Res; 2023 Jan; 189():107065. PubMed ID: 36516565
[TBL] [Abstract][Full Text] [Related]
10. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
[TBL] [Abstract][Full Text] [Related]
11. Update on the genetics of the epilepsy-aphasia spectrum and role of GRIN2A mutations.
Lesca G; Møller RS; Rudolf G; Hirsch E; Hjalgrim H; Szepetowski P
Epileptic Disord; 2019 Jun; 21(S1):41-47. PubMed ID: 31149903
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency - molecular profiling and functional rescue.
Addis L; Virdee JK; Vidler LR; Collier DA; Pal DK; Ursu D
Sci Rep; 2017 Feb; 7(1):66. PubMed ID: 28242877
[TBL] [Abstract][Full Text] [Related]
13. [Study of GRIN2A mutation in epilepsy-aphasia spectrum disorders].
Qian P; Yang X; Xu X; Liu X; Zhang Y; Yang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):314-318. PubMed ID: 29896722
[TBL] [Abstract][Full Text] [Related]
14. GRIN2A mutations cause epilepsy-aphasia spectrum disorders.
Carvill GL; Regan BM; Yendle SC; O'Roak BJ; Lozovaya N; Bruneau N; Burnashev N; Khan A; Cook J; Geraghty E; Sadleir LG; Turner SJ; Tsai MH; Webster R; Ouvrier R; Damiano JA; Berkovic SF; Shendure J; Hildebrand MS; Szepetowski P; Scheffer IE; Mefford HC
Nat Genet; 2013 Sep; 45(9):1073-6. PubMed ID: 23933818
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy: GRIN2A mutations identified as key genetic drivers of epilepsy-aphasia spectrum disorders.
Kingwell K
Nat Rev Neurol; 2013 Oct; 9(10):541. PubMed ID: 23999465
[No Abstract] [Full Text] [Related]
16. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
17. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
[TBL] [Abstract][Full Text] [Related]
18. Functional Properties of Human NMDA Receptors Associated with Epilepsy-Related Mutations of GluN2A Subunit.
Sibarov DA; Bruneau N; Antonov SM; Szepetowski P; Burnashev N; Giniatullin R
Front Cell Neurosci; 2017; 11():155. PubMed ID: 28611597
[TBL] [Abstract][Full Text] [Related]
19. Transient microstructural brain anomalies and epileptiform discharges in mice defective for epilepsy and language-related NMDA receptor subunit gene Grin2a.
Salmi M; Bolbos R; Bauer S; Minlebaev M; Burnashev N; Szepetowski P
Epilepsia; 2018 Oct; 59(10):1919-1930. PubMed ID: 30146685
[TBL] [Abstract][Full Text] [Related]
20. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.
Lemke JR; Lal D; Reinthaler EM; Steiner I; Nothnagel M; Alber M; Geider K; Laube B; Schwake M; Finsterwalder K; Franke A; Schilhabel M; Jähn JA; Muhle H; Boor R; Van Paesschen W; Caraballo R; Fejerman N; Weckhuysen S; De Jonghe P; Larsen J; Møller RS; Hjalgrim H; Addis L; Tang S; Hughes E; Pal DK; Veri K; Vaher U; Talvik T; Dimova P; Guerrero López R; Serratosa JM; Linnankivi T; Lehesjoki AE; Ruf S; Wolff M; Buerki S; Wohlrab G; Kroell J; Datta AN; Fiedler B; Kurlemann G; Kluger G; Hahn A; Haberlandt DE; Kutzer C; Sperner J; Becker F; Weber YG; Feucht M; Steinböck H; Neophythou B; Ronen GM; Gruber-Sedlmayr U; Geldner J; Harvey RJ; Hoffmann P; Herms S; Altmüller J; Toliat MR; Thiele H; Nürnberg P; Wilhelm C; Stephani U; Helbig I; Lerche H; Zimprich F; Neubauer BA; Biskup S; von Spiczak S
Nat Genet; 2013 Sep; 45(9):1067-72. PubMed ID: 23933819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
